Under homeostatic conditions, the body is maintained in a finely tuned balance of coagulation and fibrinolysis. See Figure 1 for a depiction of normal hemostasis. The activation of the coagulation ...
The second component of Virhow's triad is blood coagulation factors (proteins present in plasma). These factors may be roughly divided into two groups: zymogen (proenzymes that can be converted into ...
The tide of the blood coagulation cascade turns by a switch in thrombin specificity. Two new structures reveal how thrombomodulin's EGF domains flip the switch by blocking old substrates and docking ...
The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...
Blood coagulation is a balancing act. Too much clotting can lead to strokes. But not enough clotting can lead to uncontrolled bleeding. That balance is particularly important for patients with ...
Scientists have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin. Their work shows how cancer cells may be taking advantage of this process, and opens new ...
Using a high-sensitivity blood test (SMAT) that measures initial thrombin generation (ITG)—the very first step of blood clot formation—the researchers analyzed blood samples from 771 patients with ...
Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). This is an ASCO Meeting Abstract from the 2016 ...
Hemophilia is an X-linked bleeding disorder resulting from a deficiency of coagulation factor VIII or IX (causing hemophilia A or B, respectively) and is characterized by spontaneous and traumatic ...
ACTIVE bleeding, the threat of bleeding or bleeding in the immediate past remains the only definite contraindication to the use of artificial-kidney hemodialysis. 1–3 Predialysis heparinization of the ...
Thrombin [bovine origin] 5000 IU, 20000 IU; per vial; pwd for topical use after reconstitution; preservative-free. Thrombin-JMI requires no intermediate physiological agent for its action. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results